Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 116

1.

Tumor-derived factors modulating dendritic cell function.

Zong J, Keskinov AA, Shurin GV, Shurin MR.

Cancer Immunol Immunother. 2016 Mar 16. [Epub ahead of print] Review.

PMID:
26984847
2.

Redefining cancer immunotherapy-optimization, personalization, and new predictive biomarkers: 4th Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, April 27-30, 2015, Ljubljana, Slovenia.

Aptsiauri N, Jewett A, Hurwitz AA, Shurin MR, Umansky V.

Cancer Immunol Immunother. 2016 Jan 25. [Epub ahead of print] No abstract available.

PMID:
26810566
3.

Enzymatic oxidative biodegradation of nanoparticles: Mechanisms, significance and applications.

Vlasova II, Kapralov AA, Michael ZP, Burkert SC, Shurin MR, Star A, Shvedova AA, Kagan VE.

Toxicol Appl Pharmacol. 2016 May 15;299:58-69. doi: 10.1016/j.taap.2016.01.002. Epub 2016 Jan 6.

PMID:
26768553
4.

Payload drug vs. nanocarrier biodegradation by myeloperoxidase- and peroxynitrite-mediated oxidations: pharmacokinetic implications.

Seo W, Kapralov AA, Shurin GV, Shurin MR, Kagan VE, Star A.

Nanoscale. 2015 May 21;7(19):8689-94. doi: 10.1039/c5nr00251f.

5.

MDSC and TGFβ Are Required for Facilitation of Tumor Growth in the Lungs of Mice Exposed to Carbon Nanotubes.

Shvedova AA, Kisin ER, Yanamala N, Tkach AV, Gutkin DW, Star A, Shurin GV, Kagan VE, Shurin MR.

Cancer Res. 2015 Apr 15;75(8):1615-23. doi: 10.1158/0008-5472.CAN-14-2376. Epub 2015 Mar 5.

6.

Resolving Transferrin Isoforms via Agarose Gel Electrophoresis.

Anani WQ, Ojerholm E, Shurin MR.

Lab Med. 2015 Winter;46(1):26-33. doi: 10.1309/LMVS2JB8JZN8MDVM.

7.

Nano-gold corking and enzymatic uncorking of carbon nanotube cups.

Zhao Y, Burkert SC, Tang Y, Sorescu DC, Kapralov AA, Shurin GV, Shurin MR, Kagan VE, Star A.

J Am Chem Soc. 2015 Jan 21;137(2):675-84. doi: 10.1021/ja511843w. Epub 2015 Jan 7.

8.

Abnormalities in the male reproductive system after exposure to diesel and biodiesel blend.

Kisin ER, Yanamala N, Farcas MT, Gutkin DW, Shurin MR, Kagan VE, Bugarski AD, Shvedova AA.

Environ Mol Mutagen. 2015 Mar;56(2):265-76. doi: 10.1002/em.21915. Epub 2014 Oct 18.

PMID:
25327512
9.

Myeloid regulatory cells in tumor spreading and metastasis.

Keskinov AA, Shurin MR.

Immunobiology. 2015 Feb;220(2):236-42. doi: 10.1016/j.imbio.2014.07.017. Epub 2014 Jul 23. Review.

PMID:
25178934
10.

C-reactive protein and lung diseases.

Agassandian M, Shurin GV, Ma Y, Shurin MR.

Int J Biochem Cell Biol. 2014 Aug;53:77-88. doi: 10.1016/j.biocel.2014.05.016. Epub 2014 May 19. Review.

PMID:
24853773
11.

Graphene oxide attenuates Th2-type immune responses, but augments airway remodeling and hyperresponsiveness in a murine model of asthma.

Shurin MR, Yanamala N, Kisin ER, Tkach AV, Shurin GV, Murray AR, Leonard HD, Reynolds JS, Gutkin DW, Star A, Fadeel B, Savolainen K, Kagan VE, Shvedova AA.

ACS Nano. 2014 Jun 24;8(6):5585-99. doi: 10.1021/nn406454u. Epub 2014 May 23.

12.

Origin and pharmacological modulation of tumor-associated regulatory dendritic cells.

Zhong H, Gutkin DW, Han B, Ma Y, Keskinov AA, Shurin MR, Shurin GV.

Int J Cancer. 2014 Jun 1;134(11):2633-45. doi: 10.1002/ijc.28590. Epub 2014 Jan 20.

13.

Immunological Mechanisms of Low and Ultra-Low Dose Cancer Chemotherapy.

Landreneau JP, Shurin MR, Agassandian MV, Keskinov AA, Ma Y, Shurin GV.

Cancer Microenviron. 2015 Aug;8(2):57-64. doi: 10.1007/s12307-013-0141-3. Epub 2013 Nov 29.

14.

Cellular and molecular pathways in the tumor immunoenvironment: 3rd Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, 22-25 April 2013, Krakow, Poland.

Shurin MR, Umansky V, Malyguine A, Hurwitz AA, Apte RN, Whiteside T, Jewett A, Thanavala Y, Murphy WJ.

Cancer Immunol Immunother. 2014 Jan;63(1):73-80. doi: 10.1007/s00262-013-1501-z. Epub 2013 Nov 24. No abstract available.

PMID:
24271210
15.

Clinical evaluation of systemic and local immune responses in cancer: time for integration.

Gutkin DW, Shurin MR.

Cancer Immunol Immunother. 2014 Jan;63(1):45-57. doi: 10.1007/s00262-013-1480-0. Epub 2013 Oct 8.

16.

Biodiesel versus diesel exposure: enhanced pulmonary inflammation, oxidative stress, and differential morphological changes in the mouse lung.

Yanamala N, Hatfield MK, Farcas MT, Schwegler-Berry D, Hummer JA, Shurin MR, Birch ME, Gutkin DW, Kisin E, Kagan VE, Bugarski AD, Shvedova AA.

Toxicol Appl Pharmacol. 2013 Oct 15;272(2):373-83. doi: 10.1016/j.taap.2013.07.006. Epub 2013 Jul 22.

17.

Immunosuppressive mechanisms of regulatory dendritic cells in cancer.

Shurin GV, Ma Y, Shurin MR.

Cancer Microenviron. 2013 Aug;6(2):159-67. doi: 10.1007/s12307-013-0133-3. Epub 2013 Jun 9.

18.

Dual acute proinflammatory and antifibrotic pulmonary effects of short palate, lung, and nasal epithelium clone-1 after exposure to carbon nanotubes.

Di YP, Tkach AV, Yanamala N, Stanley S, Gao S, Shurin MR, Kisin ER, Kagan VE, Shvedova A.

Am J Respir Cell Mol Biol. 2013 Nov;49(5):759-67. doi: 10.1165/rcmb.2012-0435OC.

19.

The role of TLR4 in the paclitaxel effects on neuronal growth in vitro.

Ustinova EE, Shurin GV, Gutkin DW, Shurin MR.

PLoS One. 2013;8(2):e56886. doi: 10.1371/journal.pone.0056886. Epub 2013 Feb 18.

20.

Dendritic cells in the cancer microenvironment.

Ma Y, Shurin GV, Peiyuan Z, Shurin MR.

J Cancer. 2013;4(1):36-44. doi: 10.7150/jca.5046. Epub 2012 Dec 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk